EOLAS THERAPEUTICS, INC.

City:

Carlsbad, California

Country:

United States

Published Applications:

Last publication date:

2022-12-01

Patent Grants:

Last grant date:

2024-09-10

Top Inventors for applications by EOLAS THERAPEUTICS, INC.

These are the the leading inventors for applications assigned to EOLAS THERAPEUTICS, INC.:

Theodore M. KAMENECKA 7 Palm Beach Gardens, FL United States
Yuanjun He 7 Palm Beach Gardens, FL United States
Steven Wesolowski 3 Natick, MA United States
Xinyi Song 3 Bristol, PA United States

Roland Bürli 3 Hertfordshire, United Kingdom
Rong Jiang 3 Millersville, MD United States
William NGUYEN 3 Jupiter, FL United States
Robert Jason Herr 3 Voorheesville, NY United States

Qin Jiang 3 Latham, NY United States
Jörg Holenz 3 Bolton, MA United States
Xinyi Song 2 Carlsbad, CA United States
Rong Jiang 1 Fuquay Varina, NC United States

Rong Jiang 1 Fuguay Varina, NC United States

Recent patent applications by EOLAS THERAPEUTICS, INC.

EOLAS THERAPEUTICS, INC. based in Carlsbad, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-12-01 ✅ Patent 12,084,437 granted on 2024-09-10

US20220380359A1

Chemistry; metallurgy

Halo-substituted piperidines as orexin receptor modulators

#2 | 2021-07-15 ✅ Patent 11,434,236 granted on 2022-09-06

US20210214348A1

Chemistry; metallurgy

Halo-substituted piperidines as orexin receptor modulators

#3 | 2019-05-09 ✅ Patent 10,894,789 granted on 2021-01-19

US20190135800A1

Chemistry; metallurgy

Halo-substituted piperidines as orexin receptor modulators

#4 | 2017-08-10 ✅ Patent 10,221,170 granted on 2019-03-05

US20170226103A1

Chemistry; metallurgy

Difluoropyrrolidines as orexin receptor modulators

#5 | 2017-04-13 ✅ Patent 9,896,452 granted on 2018-02-20

US20170101410A1

Chemistry; metallurgy

Substituted prolines/piperidines as orexin receptor antagonists

#6 | 2014-12-11 ✅ Patent 9,440,982 granted on 2016-09-13

US20140364433A1

Chemistry; metallurgy

Substituted prolines/piperidines as orexin receptor antagonists

#7 | 2014-12-11 ✅ Patent 9,499,517 granted on 2016-11-22

US20140364432A1

Chemistry; metallurgy

Substituted prolines / piperidines as orexin receptor antagonists

Also check out EOLAS THERAPEUTICS, INC.'s (Carlsbad, United States) applicant profile with 8 patent applications submitted.

AssigneeID:

385703 ⎘